Results
1870
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
1870 companies
Source Natural Foods and Herbal Supplements
Market Cap: ₹914.0m
Manufactures and sells ayurveda, health and dietary supplements, and food products in India.
531398
₹138.40
7D
0.07%
1Y
-31.3%
Yuhan
Market Cap: ₩8.8t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩118,000.00
7D
0.9%
1Y
-22.0%
Jilin Aodong Pharmaceutical Group
Market Cap: CN¥22.5b
Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
CN¥19.15
7D
1.8%
1Y
29.7%
AIM Vaccine
Market Cap: HK$5.1b
Engages in the research and development, manufacture, and sale of vaccine products for human use in the People’s Republic of China.
6660
HK$4.14
7D
-7.2%
1Y
-7.0%
Welgene BiotechLtd
Market Cap: NT$522.0m
Provides genetic testing services.
6661
NT$22.40
7D
0.4%
1Y
-7.1%
Sharp Therapeutics
Market Cap: CA$15.0m
A preclinical-stage drug discovery company, develops therapeutics for genetic diseases.
SHRX
CA$0.50
7D
0%
1Y
n/a
Kainos Medicine
Market Cap: ₩35.6b
Engages in research and development of various medicines for cancers, brain, and infectious diseases in South Korea and internationally.
A284620
₩1,087.00
7D
0%
1Y
-76.9%
Vivozon Pharmaceutical
Market Cap: ₩343.4b
Researches, develops, produces, and sells LED products primarily in South Korea.
A082800
₩6,930.00
7D
-3.8%
1Y
80.0%
Wanbangde Pharmaceutical Holding Group
Market Cap: CN¥6.9b
Wanbangde Pharmaceutical Holding Group Co., Ltd.
002082
CN¥11.26
7D
-2.0%
1Y
156.5%
Walvax Biotechnology
Market Cap: CN¥18.6b
Engages in the research and development, manufacture, and distribution of vaccines in China.
300142
CN¥11.63
7D
-4.7%
1Y
4.6%
Theragen EtexLtd
Market Cap: ₩103.4b
Engages in the research and development, production, and sale of pharmaceutical products in Korea.
A066700
₩2,820.00
7D
-2.6%
1Y
-20.2%
Vasundhara Rasayans
Market Cap: ₹597.5m
Engages in the manufacture and sale of antacids therapeutic category of active pharmaceutical ingredients (API) in India and internationally.
538634
₹188.00
7D
-1.8%
1Y
-37.6%
Suzhou Zelgen Biopharmaceuticals
Market Cap: CN¥29.3b
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
688266
CN¥110.62
7D
2.3%
1Y
92.8%
Nanjing Hicin Pharmaceutical
Market Cap: CN¥6.9b
Engages in the research, development, production, and sale of chemical preparations, APIs, and intermediates.
300584
CN¥57.90
7D
-8.1%
1Y
204.4%
Cutia Therapeutics
Market Cap: HK$3.1b
An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.
2487
HK$8.79
7D
-9.4%
1Y
-42.3%
Jinhe Biotechnology
Market Cap: CN¥5.0b
Produces and sells veterinary medicines in China.
002688
CN¥6.61
7D
-4.8%
1Y
74.4%
Hunan Fangsheng Pharmaceutical
Market Cap: CN¥5.2b
Engages in research, develops, produces, and sells traditional Chinese medicine industry and chemical pharmaceutical products in China.
603998
CN¥11.83
7D
7.3%
1Y
11.9%
NeuroScientific Biopharmaceuticals
Market Cap: AU$54.9m
Engages in the research and development of novel peptide-based pharmaceutical products.
NSB
AU$0.17
7D
0%
1Y
323.1%
BF Biosciences
Market Cap: PK₨14.3b
A diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products.
BFBIO
PK₨161.64
7D
-4.0%
1Y
n/a
Indo-Bangla Pharmaceuticals
Market Cap: ৳1.6b
Engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally.
IBP
৳13.50
7D
1.5%
1Y
27.4%
Wuhan Hiteck Biological PharmaLtd
Market Cap: CN¥4.6b
A biopharmaceutical company, engages in the research and development, production, and sale of bio engineering products and freeze-dried powder injection in China.
300683
CN¥34.89
7D
-8.5%
1Y
58.9%
Jinling Pharmaceutical
Market Cap: CN¥4.3b
Manufactures and sells pharmaceutical products and medical devices in China.
000919
CN¥6.84
7D
-2.1%
1Y
10.3%
Ishita Drugs and Industries
Market Cap: ₹251.5m
Manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally.
524400
₹84.11
7D
6.3%
1Y
6.5%
PolyPeptide Group
Market Cap: CHF 791.8m
Operates as a contract development and manufacturing company in Europe, the United States, and India.
PPGN
CHF 24.00
7D
-8.0%
1Y
-24.1%
Christina Lake Cannabis
Market Cap: CA$9.9m
A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.
CLC
CA$0.04
7D
-11.1%
1Y
14.3%
Diagonal Bio
Market Cap: SEK 13.1m
Operates as a biotechnology company in Sweden.
DIABIO
SEK 0.008
7D
0%
1Y
-11.1%
ImmuPharma
Market Cap: UK£52.7m
A biopharmaceutical company, discovers and develops peptide-based therapeutics in the United Kingdom.
IMM
UK£0.10
7D
-13.8%
1Y
470.8%
Formycon
Market Cap: €398.3m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€22.55
7D
-1.7%
1Y
-57.2%
Newron Pharmaceuticals
Market Cap: CHF 209.6m
A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.
NWRN
CHF 10.50
7D
1.0%
1Y
39.6%
ALX Oncology Holdings
Market Cap: US$83.0m
A clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.
ALXO
US$1.79
7D
64.2%
1Y
-4.3%
Maravai LifeSciences Holdings
Market Cap: US$694.6m
A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.
MRVI
US$2.69
7D
-6.6%
1Y
-67.8%
cbdMD
Market Cap: US$6.0m
Produces and distributes various cannabidiol (CBD) products in the United States.
YCBD
US$0.60
7D
-16.3%
1Y
-84.0%
Enanta Pharmaceuticals
Market Cap: US$167.0m
A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.
ENTA
US$7.75
7D
-1.1%
1Y
-26.0%
Verona Pharma
Market Cap: US$9.2b
A biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs.
VRNA
US$106.69
7D
0.4%
1Y
286.0%
LakeShore Biopharma
Market Cap: US$33.0m
A biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer.
LSBC.F
US$0.73
7D
-7.6%
1Y
-90.6%
Alzamend Neuro
Market Cap: US$7.5m
A clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders.
ALZN
US$2.36
7D
-5.2%
1Y
-84.7%